These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37741045)

  • 1. DNA-dependent protein kinase catalytic subunit (DNA-PKcs) drives angiotensin II-induced vascular remodeling through regulating mitochondrial fragmentation.
    Wang L; Wu L; Du Y; Wang X; Yang B; Guo S; Zhou Y; Xu Y; Yang S; Zhang Y; Ren J
    Redox Biol; 2023 Nov; 67():102893. PubMed ID: 37741045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diallyl Trisulfide Suppresses Angiotensin II-Induced Vascular Remodeling Via Inhibition of Mitochondrial Fission.
    Lu ZY; Qi J; Yang B; Cao HL; Wang RY; Wang X; Chi RF; Guo CL; Yang ZM; Liu HM; Li B
    Cardiovasc Drugs Ther; 2020 Oct; 34(5):605-618. PubMed ID: 32564303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VSMC-Specific Deletion of FAM3A Attenuated Ang II-Promoted Hypertension and Cardiovascular Hypertrophy.
    Xiang R; Chen J; Li S; Yan H; Meng Y; Cai J; Cui Q; Yang Y; Xu M; Geng B; Yang J
    Circ Res; 2020 Jun; 126(12):1746-1759. PubMed ID: 32279581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium/calmodulin-dependent kinase II inhibition in smooth muscle reduces angiotensin II-induced hypertension by controlling aortic remodeling and baroreceptor function.
    Prasad AM; Morgan DA; Nuno DW; Ketsawatsomkron P; Bair TB; Venema AN; Dibbern ME; Kutschke WJ; Weiss RM; Lamping KG; Chapleau MW; Sigmund CD; Rahmouni K; Grumbach IM
    J Am Heart Assoc; 2015 Jun; 4(6):e001949. PubMed ID: 26077587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DP1 (Prostaglandin D
    Zou F; Li Y; Zhang S; Zhang J
    Hypertension; 2022 Jun; 79(6):1203-1215. PubMed ID: 35354317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular smooth muscle cell-specific miRNA-214 knockout inhibits angiotensin II-induced hypertension through upregulation of Smad7.
    Li Y; Li H; Xing W; Li J; Du R; Cao D; Wang Y; Yang X; Zhong G; Zhao Y; Sun W; Liu C; Gao X; Li Y; Liu Z; Jin X; Zhao D; Tan Y; Wang Y; Liu S; Yuan M; Song J; Chang YZ; Gao F; Ling S; Li Y
    FASEB J; 2021 Nov; 35(11):e21947. PubMed ID: 34637552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular Repressor of E1A-Stimulated Genes Is a Critical Determinant of Vascular Remodeling in Response to Angiotensin II.
    Li Y; Liu Y; Tian X; Zhang Y; Song H; Liu M; Zhang X; Liu H; Zhang J; Zhang Q; Liu D; Peng C; Yan C; Han Y
    Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):485-494. PubMed ID: 28062494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orphan Nuclear Receptor Nur77 Inhibits Angiotensin II-Induced Vascular Remodeling via Downregulation of β-Catenin.
    Cui M; Cai Z; Chu S; Sun Z; Wang X; Hu L; Yi J; Shen L; He B
    Hypertension; 2016 Jan; 67(1):153-62. PubMed ID: 26597820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NLRP3 Gene Deletion Attenuates Angiotensin II-Induced Phenotypic Transformation of Vascular Smooth Muscle Cells and Vascular Remodeling.
    Ren XS; Tong Y; Ling L; Chen D; Sun HJ; Zhou H; Qi XH; Chen Q; Li YH; Kang YM; Zhu GQ
    Cell Physiol Biochem; 2017; 44(6):2269-2280. PubMed ID: 29262411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effects of astragaloside IV against angiotensin II-induced mitochondrial dysfunction in rat vascular smooth muscle cells.
    Lu Y; Li S; Wu H; Bian Z; Xu J; Gu C; Chen X; Yang D
    Int J Mol Med; 2015 Nov; 36(5):1223-32. PubMed ID: 26398547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RhoGDI stability is regulated by SUMOylation and ubiquitination via the AT1 receptor and participates in Ang II-induced smooth muscle proliferation and vascular remodeling.
    Dai F; Qi Y; Guan W; Meng G; Liu Z; Zhang T; Yao W
    Atherosclerosis; 2019 Sep; 288():124-136. PubMed ID: 31362179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCL6 Attenuates Proliferation and Oxidative Stress of Vascular Smooth Muscle Cells in Hypertension.
    Chen D; Zang YH; Qiu Y; Zhang F; Chen AD; Wang JJ; Chen Q; Li YH; Kang YM; Zhu GQ
    Oxid Med Cell Longev; 2019; 2019():5018410. PubMed ID: 30805081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consequences of postnatal vascular smooth muscle EGFR deletion on acute angiotensin II action.
    Schreier B; Hünerberg M; Rabe S; Mildenberger S; Bethmann D; Heise C; Sibilia M; Offermanns S; Gekle M
    Clin Sci (Lond); 2016 Jan; 130(1):19-33. PubMed ID: 26438881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II induces Fat1 expression/activation and vascular smooth muscle cell migration via Nox1-dependent reactive oxygen species generation.
    Bruder-Nascimento T; Chinnasamy P; Riascos-Bernal DF; Cau SB; Callera GE; Touyz RM; Tostes RC; Sibinga NE
    J Mol Cell Cardiol; 2014 Jan; 66():18-26. PubMed ID: 24445059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irisin attenuates vascular remodeling in hypertensive mice induced by Ang II by suppressing Ca
    Li RL; Zhuo CL; Yan X; Li H; Lin L; Li LY; Jiang Q; Zhang D; Wang XM; Liu LL; Huang WJ; Wang YL; Li XY; Mao Y; Chen Y; Liu X; Xu QC; Cai YY; Yang XJ; Chen HY; Wu SS; Jiang W
    Int J Biol Sci; 2024; 20(2):680-700. PubMed ID: 38169582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive oxygen species derived from NADPH oxidase 1 and mitochondria mediate angiotensin II-induced smooth muscle cell senescence.
    Tsai IC; Pan ZC; Cheng HP; Liu CH; Lin BT; Jiang MJ
    J Mol Cell Cardiol; 2016 Sep; 98():18-27. PubMed ID: 27381955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of angiotensin II activation of yes-associated protein/PDZ-binding motif signaling in hypertensive cardiac and vascular remodeling.
    Xu Q; Zhuo K; Zhang X; Zhen Y; Liu L; Zhang L; Gu Y; Jia H; Chen Q; Liu M; Dong J; Zhou MS
    Eur J Pharmacol; 2024 Jan; 962():176252. PubMed ID: 38061470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of mitochondrial morphology by positive feedback interaction between PKCδ and Drp1 in vascular smooth muscle cell.
    Lim S; Lee SY; Seo HH; Ham O; Lee C; Park JH; Lee J; Seung M; Yun I; Han SM; Lee S; Choi E; Hwang KC
    J Cell Biochem; 2015 Apr; 116(4):648-60. PubMed ID: 25399916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mas Receptor Activation Contributes to the Improvement of Nitric Oxide Bioavailability and Vascular Remodeling During Chronic AT1R (Angiotensin Type-1 Receptor) Blockade in Experimental Hypertension.
    Savoia C; Arrabito E; Parente R; Nicoletti C; Madaro L; Battistoni A; Filippini A; Steckelings UM; Touyz RM; Volpe M
    Hypertension; 2020 Dec; 76(6):1753-1761. PubMed ID: 33070664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mdivi-1, a mitochondrial fission inhibitor, reduces angiotensin-II- induced hypertension by mediating VSMC phenotypic switch.
    Deng Y; Li S; Chen Z; Wang W; Geng B; Cai J
    Biomed Pharmacother; 2021 Aug; 140():111689. PubMed ID: 34004510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.